The Delusional Misidentification Syndromes
Delusional Misidentification SyndromesEllis H.D.a · Luauté J.-P.b · Retterstøl N.c
aSchool of Psychology, University of Wales College of Cardiff, UK; bCentre Hospitalier General de Romans, France; cGaustad Hospital, University of Oslo, Norway
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The editors first describe the principal symptoms of the Capgras delusion, the FrÉgoli delusion, the delusion of intermeta-morphosis and the delusion of subjective doubles before developing the argument that it would be appropriate for international psychiatric diagnostic systems to include these disorders. Furthermore the similarity between them, the reduplicative paramnesias and dÉjÀ and jamais vu are pointed out. By stressing a symptom-based approach it is possible to examine psychiatric, neurological and medical cases as arising from the same underlying disturbance in cognition function. The relationship between delusions of misidentification and other delusions is also touched upon.
© 1994 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.